Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07434674 · ClinicalTrials.gov registry record
Incidence of Long-TeRm Atrial Fibrillation After Acute Illness
A clinical trial of Atrial Fibrillation (AF), sponsored by University of California, San Diego.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT07434674: Recruiting study of Atrial Fibrillation (AF), sponsored by University of California, San Diego.
NCT07434674 is a study of Atrial Fibrillation (AF) that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 100 participants, below the 714-participant average among 17 other Atrial Fibrillation (AF) trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07434674, a study of Atrial Fibrillation (AF), is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators seek to conduct a prospective study to assess the recurrence of AF in patients with acute AF using a long-term ECG monitoring strategy with an insertable cardiac monitor (ICM), which is clinically indicated in this scenario as part of the standard of care. The investigators hypothesize that patients diagnosed with acute AF in the setting of cardiac surgery will have higher rates of AF recurrence than acute AF diagnosed in the setting of non-cardiac surgery or medical illness.
Primary Outcome
The primary objective is to determine the time to first documented event of AF by 12 months of continuous rhythm monitoring, stratified by the setting of acute AF diagnosis (cardiac surgery, non-cardiac surgery, and medical illness).
Conditions Studied
Study Locations (1)
California
- Sulpizio Cardiovascular Center - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2027-12 |
What NCT07434674 shows while recruiting
NCT07434674 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 714-participant average among 17 other Atrial Fibrillation (AF) trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Atrial Fibrillation (AF) appearing as the primary indexed condition, and to 0 interventions.
NCT07434674 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07434674 about?
NCT07434674 is a clinical study titled "Incidence of Long-TeRm Atrial Fibrillation After Acute Illness". The investigators seek to conduct a prospective study to assess the recurrence of AF in patients with acute AF using a long-term ECG monitoring strategy with an insertable cardiac monitor (ICM), which is clinically indicated in this scenario as part of the standard of care. The investigators hypothe...
What is the current status of trial NCT07434674?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-11-01. Estimated completion is 2027-12.
What conditions does trial NCT07434674 study?
This clinical trial studies the following conditions: Atrial Fibrillation (AF).
Who is sponsoring clinical trial NCT07434674?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07434674 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation (AF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07434674's enrollment target sits among peer trials
100 16th of 17 the lowest of 17 other Atrial Fibrillation (AF) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation (AF) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation Severity
RECRUITING · NA
-
Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation
RECRUITING · NA
-
Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
RECRUITING
-
Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.
RECRUITING
-
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
RECRUITING · NA
-
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI